Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cutivax
- Development stage
- Preclinical
- Lead developer
- Boğaziçi Üniversitesi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Implant, Subcutaneous
01
Overview
Cutivax is an implantable, bio-active subcutaneous immunotherapy platform designed as a biocompatible scaffold to sustain antigenic signaling in vivo. Developed by Bogazici University and Innoway R&D, the device consists of a fenestrated polytetrafluoroethylene (PTFE) scaffold enclosed within a semipermeable PTFE membrane and integrated with an injection port. When loaded with active tumor-derived cellular material, Cutivax acts as an in-situ immune-training platform, allowing the controlled diffusion of tumor-associated antigens, soluble mediators, and extracellular vesicles across its semipermeable membrane to stimulate a durable anti-tumor immune response while preventing whole-cell escape. It is currently in preclinical development for the treatment of solid tumors, including triple-negative breast cancer.
- Other names
- CUTIVAX
Beyond the preview
Go deeper on Cutivax.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cutivax.